Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Genetic variation in innate immunity and inflammation pathways associated with lung cancer risk.

Shiels MS, Engels EA, Shi J, Landi MT, Albanes D, Chatterjee N, Chanock SJ, Caporaso NE, Chaturvedi AK.

Cancer. 2012 Nov 15;118(22):5630-6. doi: 10.1002/cncr.27605. Epub 2012 Oct 8.

2.

Genetic variation on 9p22 is associated with abnormal ovarian ultrasound results in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Wentzensen N, Black A, Jacobs K, Yang HP, Berg CD, Caporaso N, Peters U, Ragard L, Buys SS, Chanock S, Hartge P.

PLoS One. 2011;6(7):e21731. doi: 10.1371/journal.pone.0021731. Epub 2011 Jul 7.

3.

An analysis of single nucleotide polymorphisms of 125 DNA repair genes in the Texas genome-wide association study of lung cancer with a replication for the XRCC4 SNPs.

Yu H, Zhao H, Wang LE, Han Y, Chen WV, Amos CI, Rafnar T, Sulem P, Stefansson K, Landi MT, Caporaso N, Albanes D, Thun M, McKay JD, Brennan P, Wang Y, Houlston RS, Spitz MR, Wei Q.

DNA Repair (Amst). 2011 Apr 3;10(4):398-407. doi: 10.1016/j.dnarep.2011.01.005. Epub 2011 Feb 5.

4.

Genetic variation in catechol-O-methyltransferase (COMT) and obesity in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial.

Wang SS, Morton LM, Bergen AW, Lan EZ, Chatterjee N, Kvale P, Hayes RB, Chanock SJ, Caporaso NE.

Hum Genet. 2007 Aug;122(1):41-9. Epub 2007 May 12.

PMID:
17497175
5.

Germline variation in NCF4, an innate immunity gene, is associated with an increased risk of colorectal cancer.

Ryan BM, Zanetti KA, Robles AI, Schetter AJ, Goodman J, Hayes RB, Huang WY, Gunter MJ, Yeager M, Burdette L, Berndt SI, Harris CC.

Int J Cancer. 2014 Mar 15;134(6):1399-407. doi: 10.1002/ijc.28457. Epub 2013 Nov 14.

6.

Association study of prostate cancer susceptibility variants with risks of invasive ovarian, breast, and colorectal cancer.

Song H, Koessler T, Ahmed S, Ramus SJ, Kjaer SK, Dicioccio RA, Wozniak E, Hogdall E, Whittemore AS, McGuire V, Ponder BA, Turnbull C, Hines S, Rahman N; Breast Cancer Susceptibility Collaboration UK, Eeles RA, Easton DF, Gayther SA, Dunning AM, Pharoah PD.

Cancer Res. 2008 Nov 1;68(21):8837-42. doi: 10.1158/0008-5472.CAN-08-2363.

7.

Multistage analysis of variants in the inflammation pathway and lung cancer risk in smokers.

Spitz MR, Gorlov IP, Dong Q, Wu X, Chen W, Chang DW, Etzel CJ, Caporaso NE, Zhao Y, Christiani DC, Brennan P, Albanes D, Shi J, Thun M, Landi MT, Amos CI.

Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1213-21. doi: 10.1158/1055-9965.EPI-12-0352-T. Epub 2012 May 9.

8.

Common genetic variants associated with disease from genome-wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis.

Orozco G, Goh CL, Al Olama AA, Benlloch-Garcia S, Govindasami K, Guy M, Muir KR, Giles GG, Severi G, Neal DE, Hamdy FC, Donovan JL, Kote-Jarai Z, Easton DF, Eyre S, Eeles RA.

BJU Int. 2013 Jun;111(7):1148-55. doi: 10.1111/j.1464-410X.2012.11492.x. Epub 2012 Sep 18.

9.

Genetic variation in innate immunity and inflammation pathways associated with lung cancer risk.

Young RP, Hopkins RJ.

Cancer. 2013 May 1;119(9):1761. doi: 10.1002/cncr.27953. Epub 2013 Jan 18. No abstract available.

10.

Common variation in genes related to innate immunity and risk of adult glioma.

Rajaraman P, Brenner AV, Butler MA, Wang SS, Pfeiffer RM, Ruder AM, Linet MS, Yeager M, Wang Z, Orr N, Fine HA, Kwon D, Thomas G, Rothman N, Inskip PD, Chanock SJ.

Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1651-8. doi: 10.1158/1055-9965.EPI-08-1041.

11.

Innate immunity gene polymorphisms and the risk of colorectal neoplasia.

Chang CM, Chia VM, Gunter MJ, Zanetti KA, Ryan BM, Goodman JE, Harris CC, Weissfeld J, Huang WY, Chanock S, Yeager M, Hayes RB, Berndt SI; Genetics and Epidemiology of Colorectal Cancer Consortium.

Carcinogenesis. 2013 Nov;34(11):2512-20. doi: 10.1093/carcin/bgt228. Epub 2013 Jun 26.

12.

Risk of meningioma and common variation in genes related to innate immunity.

Rajaraman P, Brenner AV, Neta G, Pfeiffer R, Wang SS, Yeager M, Thomas G, Fine HA, Linet MS, Rothman N, Chanock SJ, Inskip PD.

Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1356-61. doi: 10.1158/1055-9965.EPI-09-1151. Epub 2010 Apr 20.

13.

Large-scale evaluation of genetic variants in candidate genes for colorectal cancer risk in the Nurses' Health Study and the Health Professionals' Follow-up Study.

Hazra A, Chanock S, Giovannucci E, Cox DG, Niu T, Fuchs C, Willett WC, Hunter DJ.

Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):311-9. doi: 10.1158/1055-9965.EPI-07-0195.

14.

Genome-wide association study identifies a new SMAD7 risk variant associated with colorectal cancer risk in East Asians.

Zhang B, Jia WH, Matsuo K, Shin A, Xiang YB, Matsuda K, Jee SH, Kim DH, Cheah PY, Ren Z, Cai Q, Long J, Shi J, Wen W, Yang G, Ji BT, Pan ZZ, Matsuda F, Gao YT, Oh JH, Ahn YO, Kubo M, Thean LF, Park EJ, Li HL, Park JW, Jo J, Jeong JY, Hosono S, Nakamura Y, Shu XO, Zeng YX, Zheng W.

Int J Cancer. 2014 Aug 15;135(4):948-55. doi: 10.1002/ijc.28733. Epub 2014 Jan 29.

15.

TNF polymorphisms and prostate cancer risk.

Danforth KN, Rodriguez C, Hayes RB, Sakoda LC, Huang WY, Yu K, Calle EE, Jacobs EJ, Chen BE, Andriole GL, Figueroa JD, Yeager M, Platz EA, Michaud DS, Chanock SJ, Thun MJ, Hsing AW.

Prostate. 2008 Mar 1;68(4):400-7. doi: 10.1002/pros.20694.

PMID:
18196539
16.

Pooled sample-based GWAS: a cost-effective alternative for identifying colorectal and prostate cancer risk variants in the Polish population.

Gaj P, Maryan N, Hennig EE, Ledwon JK, Paziewska A, Majewska A, Karczmarski J, Nesteruk M, Wolski J, Antoniewicz AA, Przytulski K, Rutkowski A, Teumer A, Homuth G, Starzyńska T, Regula J, Ostrowski J.

PLoS One. 2012;7(4):e35307. doi: 10.1371/journal.pone.0035307. Epub 2012 Apr 19.

17.

Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer.

Quaye L, Tyrer J, Ramus SJ, Song H, Wozniak E, DiCioccio RA, McGuire V, Høgdall E, Høgdall C, Blaakaer J, Goode EL, Schildkraut JM, Easton DF, Krüger-Kjaer S, Whittemore AS, Gayther SA, Pharoah PD.

PLoS One. 2009 Jun 19;4(6):e5983. doi: 10.1371/journal.pone.0005983.

18.

The joint association of REST and NFKB1 polymorphisms on the risk of colorectal cancer.

Yu Y, Liu H, Jin M, Zhang M, Pan Y, Zhang S, Li Q, Chen K.

Ann Hum Genet. 2012 Jul;76(4):269-76. doi: 10.1111/j.1469-1809.2012.00709.x. Epub 2012 Apr 25.

19.

Prognostic value of single nucleotide polymorphisms of candidate genes associated with inflammation in early stage breast cancer.

Murray JL, Thompson P, Yoo SY, Do KA, Pande M, Zhou R, Liu Y, Sahin AA, Bondy ML, Brewster AM.

Breast Cancer Res Treat. 2013 Apr;138(3):917-24. doi: 10.1007/s10549-013-2445-x. Epub 2013 Mar 26.

20.

Association of CD14 variant with prostate cancer in African American men.

Mason TE, Ricks-Santi L, Chen W, Apprey V, Joykutty J, Ahaghotu C, Kittles R, Bonney G, Dunston GM.

Prostate. 2010 Feb 15;70(3):262-9. doi: 10.1002/pros.21060.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk